Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study

Table 4 Direct medical costs associated with TDT treatment by the type of service per patient per year (N = 255)

Service type	Average cost	Median	Min	Max	Total cost / year
Laboratory investigations	9,069	8,182	4,849	28,882	2,312,595
Radiology investigations	1,754	1,125	0	10,533	447,326
ICT	78,372	75,842	704	278,334	19,984,956
DFX	88,929	85,861	2,505	278,334	16,096,176
DFP	31,123	20,855	2,827	104,569	432,348
DFO	28,058	22,825	0	122,582	982,027
Combined therapy	91,586	83,630	18,508	147,234	2,564,405
Other medications	4,414	1,496	165	92,834	1,125,540
Blood transfusions	34,223	34,850	5,950	69,700	8,726,950
Consultations	2,142	1,246	0	21,265	546,115
Surgical procedures	1,182	0	0	33,004	301,361
Total cost/year (AED) = 33,444,843
Average cost/ patient/ year (AED) = 131,156
Median cost/ patient/ year (AED) = 128,258
Minimum cost/ patient/ year (AED) = 26,128
Maximum cost/ patient/ year (AED) = 361,672

ICT iron chelation therapy, DFX deferasirox, DFP deferiprone, DFO deferoxamine

ISSN: 1472-6963